Roivios

Roivios is a clinical-stage medical device company dedicated to providing groundbreaking solutions for kidney health. Its lead product, the JuxtaFlow® Renal Assist Device (RAD), aims to protect kidney function and offer a preemptive approach to managing kidney disease, demonstrating its effectiveness in improving renal outcomes, potentially reducing dialysis needs, and lowering healthcare costs. The company holds proprietary patents for critical renal technologies with the goal of revolutionizing kidney disease management. Roivios plans to expand its applications from kidney disease to various medical settings and is preparing to launch a transformative product in the United States by 2025, aiming to redefine kidney disease management and improve patients' quality of life.